FDA Approved: VORICONAZOLE — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

The FDA approved Glenmark's original application for a generic Voriconazole (ANDA 203503), enabling the generic antifungal to be marketed in the United States.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia
• Esophageal Candidiasis
• Invasive Aspergillosis

Drugs mentioned

• VORICONAZOLE (Voriconazole)

Snippet

ORIG AP for VORICONAZOLE (VORICONAZOLE)